Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy
about
Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation.Determinants of reduced health-related quality of life in pediatric inherited neuropathies.The PMP22 gene and its related diseases.Endoplasmic reticulum stress in disorders of myelinating cells.Membrane-thinning effect of curcumin.Inherited peripheral neuropathies.The bound states of amphipathic drugs in lipid bilayers: study of curcumin.Update on Charcot-Marie-Tooth disease.Molecular mechanisms of inherited demyelinating neuropathies.Long-term analyses of innervation and neuromuscular integrity in the Trembler-J mouse model of Charcot-Marie-Tooth diseaseCurcumin facilitates a transitory cellular stress response in Trembler-J mice.The CMT4B disease-causing proteins MTMR2 and MTMR13/SBF2 regulate AKT signallingExperimental therapeutics in hereditary neuropathies: the past, the present, and the future.Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease.Cellular Pathology of Pelizaeus-Merzbacher Disease Involving Chaperones Associated with Endoplasmic Reticulum StressDemyelinating prenatal and infantile developmental neuropathies.Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.Neural and molecular features on Charcot-Marie-Tooth disease plasticity and therapy.Animal models and therapeutic prospects for Charcot-Marie-Tooth disease.Naturally occurring plant polyphenols as potential therapies for inherited neuromuscular diseases.Charcot-Marie-Tooth disease and pathways to molecular based therapies.Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).Therapeutic options in Charcot-Marie-Tooth diseases.A Review of X-linked Charcot-Marie-Tooth Disease.Promoting peripheral myelin repair.Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders.Unfolded protein response, treatment and CMT1B.A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease.PMP22 exon 4 deletion causes ER retention of PMP22 and a gain-of-function allele in CMT1E.The Charcot-Marie-Tooth diseases: how can we identify and develop novel therapeutic targets?Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.Genomic disorders 20 years on-mechanisms for clinical manifestations.Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease.Efficacy of exogenous pyruvate in Trembler mouse model of Charcot-Marie-Tooth neuropathy
P2860
Q33954730-D0384DA2-E75C-461B-8671-4FFFCC4DCD01Q34098654-3CAA8F96-79C9-4A83-95D4-27B40649BC08Q34316615-09FAD41B-37BF-4307-9C07-4150DC5D6CC1Q34962824-823D72DF-5975-4327-94E7-614E28E2DA7BQ36785193-39C55A82-F508-45E0-B7FA-0B5813A4538CQ36822088-5EDBE7A8-E26F-483D-9A9B-EBC61B39E436Q36838844-88B03EB8-64EF-44E0-864A-B028E90A373DQ36937164-0ADF65D1-F07F-4C65-A8AF-0462093B5480Q36942808-05EE45B0-C6C0-444C-8B49-483B4D7C5A3DQ37262610-2A69249A-FCE6-4AC8-A9B7-61A9EA70C2D2Q37286986-83C370C2-13C6-4B16-A80E-546B977D5955Q37294507-E0415B01-E156-4C17-A9E4-B519ED678BE3Q37329508-7FA0090B-55CB-4DF9-8974-3A2DAD2C1362Q37377545-C96C0CA5-9E79-40C7-9BFA-63CFEE9F4B6CQ37662537-FBC14B30-ECA8-44A0-B0D7-DD1FBA54B324Q37998518-4A8B7078-076C-4127-A2A9-EB206A7C959AQ38007033-FE549D4B-17A1-4200-A853-17DE1AF9310AQ38022624-B753B383-2A69-4DE8-8C3F-1DA44E015FCDQ38126454-4C37B1DC-AE21-4665-89E8-E35E99BED72AQ38161550-8E8AAE0F-F5FC-4D8E-B31B-33FCB383A0EAQ38201741-9C0B34E4-2EEA-4561-8156-81D981484CE6Q38314584-42436588-7A71-4F4A-81E1-810C2D92CA31Q38363677-EFF5A743-C28E-44F9-948D-6D5B969613E0Q38589445-7ACF4474-1FBE-4D55-8FCB-4430D8CEF991Q38808666-A9C950A6-4FA7-4DEB-B8D8-F7417B411D79Q39094240-692824B1-4EB6-4627-B960-B8B2BB8B8D1DQ39496089-BEDC0476-30B1-4366-BD95-A77AB86909DBQ41295377-A86045AE-DF49-48A7-8EDD-4655ECDF4685Q42293062-716186C6-77F2-4784-924F-FAFC67752061Q42416075-76EC8CB6-1BC4-481D-B840-00BE9785DFACQ42996652-98E9AB55-D7F5-4473-AE4F-BEDF69FBE96AQ43244008-2452EC07-4BA0-4879-9845-D13461302957Q46300376-6A799ED3-DF78-45EF-B09E-172CEAAF812AQ53370571-9A4AFEEB-7D1F-4AC8-AC6C-F0FE33B89526Q58702974-C4CBAF59-DC97-4FD6-A5A7-96498DB7B600
P2860
Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oral curcumin mitigates the cl ...... erapy for inherited neuropathy
@ast
Oral curcumin mitigates the cl ...... erapy for inherited neuropathy
@en
type
label
Oral curcumin mitigates the cl ...... erapy for inherited neuropathy
@ast
Oral curcumin mitigates the cl ...... erapy for inherited neuropathy
@en
prefLabel
Oral curcumin mitigates the cl ...... erapy for inherited neuropathy
@ast
Oral curcumin mitigates the cl ...... erapy for inherited neuropathy
@en
P2093
P2860
P50
P356
P1476
Oral curcumin mitigates the cl ...... erapy for inherited neuropathy
@en
P2093
G Jackson Snipes
James R Lupski
Kensuke Shiga
Mehrdad Khajavi
Wojciech Wiszniewski
P2860
P304
P356
10.1086/519926
P407
P577
2007-08-03T00:00:00Z